Frontiers in Pharmacology (Nov 2022)
Corrigendum: Identification of an alternative glycyrrhizin metabolite causing liquorice-induced pseudohyperaldosteronism and the development of ELISA system to detect the predictive biomarker
- Kan’ichiro Ishiuchi,
- Osamu Morinaga,
- Tetsuhiro Yoshino,
- Miaki Mitamura,
- Asuka Hirasawa,
- Yasuhito Maki,
- Yuuna Tashita,
- Tsubasa Kondo,
- Kakuyou Ogawa,
- Fangyi Lian,
- Keiko Ogawa-Ochiai,
- Kiyoshi Minamizawa,
- Takao Namiki,
- Masaru Mimura,
- Kenji Watanabe,
- Toshiaki Makino
Affiliations
- Kan’ichiro Ishiuchi
- Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan
- Osamu Morinaga
- Department of Natural Medicines, Daiichi University of Pharmacy, Fukuoka, Japan
- Tetsuhiro Yoshino
- Center for Kampo Medicine, Keio University School of Medicine, Tokyo, Japan
- Miaki Mitamura
- Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan
- Asuka Hirasawa
- Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan
- Yasuhito Maki
- Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan
- Yuuna Tashita
- Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan
- Tsubasa Kondo
- Department of Natural Medicines, Daiichi University of Pharmacy, Fukuoka, Japan
- Kakuyou Ogawa
- Department of Natural Medicines, Daiichi University of Pharmacy, Fukuoka, Japan
- Fangyi Lian
- Center for Kampo Medicine, Keio University School of Medicine, Tokyo, Japan
- Keiko Ogawa-Ochiai
- Department of Otorhinolaryngology and Head and Neck Surgery, Clinic of Japanese Oriental (Kampo) Medicine, Kanazawa University Hospital, Kanazawa, Japan
- Kiyoshi Minamizawa
- Department of Oriental Medicine, Kameda Medical Center, Kamogawa, Japan
- Takao Namiki
- Department of Japanese Oriental (Kampo) Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
- Masaru Mimura
- Center for Kampo Medicine, Keio University School of Medicine, Tokyo, Japan
- Kenji Watanabe
- Center for Kampo Medicine, Keio University School of Medicine, Tokyo, Japan
- Toshiaki Makino
- Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan
- DOI
- https://doi.org/10.3389/fphar.2022.1090327
- Journal volume & issue
-
Vol. 13
Abstract
No abstracts available.Keywords